Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe J Jordan

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
British Journal of Pharmacology|August 28, 2020
(±)VK4-40, a novel dopamine D<sub>3</sub> receptor partial agonist, attenuates cocaine reward and relapse in rodentsChloe J Jordan, Yi He, Guo-Hua Bi, et al.
Acta Pharmacologica Sinica|July 4, 2018
CB<sub>2</sub> receptor antibody signal specificity: correlations with the use of partial CB<sub>2</sub>-knockout mice and anti-rat CB<sub>2</sub> receptor antibodiesHai-Ying Zhang, Hui Shen, Chloe J Jordan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 13, 2020
Dissecting the Role of GABA Neurons in the VTA <i>versus</i> SNr in Opioid RewardEwa Galaj, Xiao Han, Hui Shen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2022
Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in MiceXiao Han, Ying Liang, Briana Hempel, et al.
Neuropharmacology|August 24, 2018
Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in miceJia Zhan, Chloe J Jordan, Guo-Hua Bi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 5, 2018
Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic ratsJun-Tao Gao, Chloe J Jordan, Guo-Hua Bi, et al.
Neuropharmacology|July 27, 2020
Xie2-64, a novel CB<sub>2</sub> receptor inverse agonist, reduces cocaine abuse-related behaviors in rodentsChloe J Jordan, Zhi-Wei Feng, Ewa Galaj, et al.
Developmental Cognitive Neuroscience|August 22, 2024
Communications, engagement, and dissemination strategies for the HEALthy Brain and Child Development (HBCD) StudyKatherine M Cole, Chloe J Jordan, Micaela Parkinson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2019
Newly Developed Dopamine D<sub>3</sub> Receptor Antagonists, <i>R</i>-VK4-40 and <i>R</i>-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in RatsChloe J Jordan, Bree A Humburg, Eric B Thorndike, et al.
Acta Pharmacologica Sinica|July 4, 2018
Cannabinoid CB<sub>1</sub> receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in ratsXiang-Hu He, Chloe J Jordan, Kiran Vemuri, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Pharmacology|August 28, 2020
(±)VK4-40, a novel dopamine D<sub>3</sub> receptor partial agonist, attenuates cocaine reward and relapse in rodentsChloe J Jordan, Yi He, Guo-Hua Bi, et al.
Acta Pharmacologica Sinica|July 4, 2018
CB<sub>2</sub> receptor antibody signal specificity: correlations with the use of partial CB<sub>2</sub>-knockout mice and anti-rat CB<sub>2</sub> receptor antibodiesHai-Ying Zhang, Hui Shen, Chloe J Jordan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 13, 2020
Dissecting the Role of GABA Neurons in the VTA <i>versus</i> SNr in Opioid RewardEwa Galaj, Xiao Han, Hui Shen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2022
Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in MiceXiao Han, Ying Liang, Briana Hempel, et al.
Neuropharmacology|August 24, 2018
Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in miceJia Zhan, Chloe J Jordan, Guo-Hua Bi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 5, 2018
Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic ratsJun-Tao Gao, Chloe J Jordan, Guo-Hua Bi, et al.
Neuropharmacology|July 27, 2020
Xie2-64, a novel CB<sub>2</sub> receptor inverse agonist, reduces cocaine abuse-related behaviors in rodentsChloe J Jordan, Zhi-Wei Feng, Ewa Galaj, et al.
Developmental Cognitive Neuroscience|August 22, 2024
Communications, engagement, and dissemination strategies for the HEALthy Brain and Child Development (HBCD) StudyKatherine M Cole, Chloe J Jordan, Micaela Parkinson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2019
Newly Developed Dopamine D<sub>3</sub> Receptor Antagonists, <i>R</i>-VK4-40 and <i>R</i>-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in RatsChloe J Jordan, Bree A Humburg, Eric B Thorndike, et al.
Acta Pharmacologica Sinica|July 4, 2018
Cannabinoid CB<sub>1</sub> receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in ratsXiang-Hu He, Chloe J Jordan, Kiran Vemuri, et al.
Pageof 5